Varenicline Tartrate Nasal Spray(Oyster/Corxel )

酒石酸伐尼克兰鼻喷雾剂（Oyster/箕星药业）

Report date: 2025/02/10 20:00:43

Base Information

Drug NameVarenicline Tartrate Nasal Spray(Oyster/Corxel )
Drug Alias Name酒石酸伐尼克兰改良型 (Oyster/箕星药业)星特润TyrvayaOC-01（varenicline）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic acetylcholine receptor alpha-4/beta-2 agonists
TargetsNicotinic acetylcholine receptor alpha-4/beta-2
Therapy Area/IndicationsDry Eye SyndromesXerophthalmia
Global Approved IndicationsXerophthalmia
Approved Indications in ChinaXerophthalmia
Original Approved Country/TerritoryUnited States
Original Approved Date2021/10/15
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOyster Point Pharma IncCorxel Pharmaceuticals (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOyster Point Pharma IncJi Xing Pharmaceuticals LtdCorxel Pharmaceuticals (Shanghai) Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsDry Eye SyndromesXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG